Samarth Kulkarni, Crispr Therapeutics CEO, joins 'Power Lunch' to discuss the hurdles to getting rare disease drugs through regulation, what consumers can look forward to in gene editing, and much more.
The first of anything tends to be expensive. Remember when taking a cruise or a flight across the Ocean was impossible, then they said only for the super wealthy? Kinda dystopian.
Why would you change it? It would legit change EVERYTHING in them. I just feel like society treats them the same as homosexuals in the 50's, just my takeway tho.
We've heard all this crap before.... They're always 10 to 15 years away, 10 to 15 years away, 10 to 15 years away... They've been saying this crap for the last 30 years. I for one am not impressed.
Social and ethical aspects are critical when this tech is urtilized. Good thing to remember is that getting therapy or medication for rare genetic diseases will mean that it will help your own descendants too! If helping others does not motivate so much😂
The common cold isn't the same cold every year. It constantly mutates and is a new virus each time, so it's quite feeble minded to expect a "one cure for all" for the common cold for all of time.
